These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5727860)

  • 1. Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level.
    Stokes GS; Gentle JL; Edwards KD; Stewart JH
    Med J Aust; 1968 Dec; 2(23):1050-4. PubMed ID: 5727860
    [No Abstract]   [Full Text] [Related]  

  • 2. The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
    Klemm SA; Gordon RD; Tunny TJ; Thompson RE
    Clin Invest Med; 1991 Dec; 14(6):551-8. PubMed ID: 1838973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-aldosterone in elderly patients with hyperkalaemia under anaesthesia.
    Kudoh A; Sakai T; Ishihara H; Matsuki A
    Eur J Anaesthesiol; 1999 Apr; 16(4):231-5. PubMed ID: 10234492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and hyperkalaemia responding to bendrofluazide.
    Lee MR; Ball SG; Thomas TH; Morgan DB
    Q J Med; 1979 Apr; 48(190):245-58. PubMed ID: 504550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.
    Zanella MT; Mattei E; Draibe SA; Kater CE; Ajzen H
    Clin Pharmacol Ther; 1985 Dec; 38(6):613-7. PubMed ID: 2998675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone.
    Arruda JA; Batlle DC; Sehy JT; Roseman MK; Baronowski RL; Kurtzman NA
    Am J Nephrol; 1981; 1(3-4):160-7. PubMed ID: 6758577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical correction in the syndrome of hypertension and hyperkalaemia by severe dietary salt restriction suggests renin-aldosterone suppression critical in pathophysiology.
    Klemm SA; Gordon RD; Tunny TJ; Finn WL
    Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):191-5. PubMed ID: 2187635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-aldosterone system in low-dose chlorothiazide treatment of hypertensive subjects.
    Lammintausta R; Lammintausta K
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):329-31. PubMed ID: 6997221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of plasma renin activity in a boy with chronic hyperkalemia.
    Sauder SE; Kelch RP; Grekin RJ; Kelsch RC
    Am J Dis Child; 1987 Aug; 141(8):922-7. PubMed ID: 3307388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
    Guthrie GP; Kotchen TA
    Am J Med; 1979 Sep; 67(3):524-8. PubMed ID: 474601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atrial natriuretic factor on the plasma aldosterone response to potassium infusion in rats--in vivo study.
    Takagi M; Franco-Saenz R; Mulrow PJ
    Life Sci; 1986 Jul; 39(4):359-64. PubMed ID: 2942746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The syndrome of hypertension and hyperkalaemia with normal GFR. A unique pathophysiological mechanism for hypertension?
    Gordon RD
    Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):329-33. PubMed ID: 3524920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalaemia secondary to hypo-aldosteronism. A report of 2 cases differentiating hyperreninaemic from hyporeninaemic hypo-aldosteronism.
    Diamond TH; Huddle KR; Dubb A
    S Afr Med J; 1987 Jan; 71(1):40-2. PubMed ID: 3541255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
    Farfel Z; Iaina A; Rosenthal T; Waks U; Shibolet S; Gafni J
    Arch Intern Med; 1978 Dec; 138(12):1828-32. PubMed ID: 718348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of KCl infusion on renin secretory rates and aldosterone excretion in dogs.
    Flamenbaum W; Kleinman JG; McNeil JS; Hamburger RJ; Kotchen TA
    Am J Physiol; 1975 Aug; 229(2):370-5. PubMed ID: 1163662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH; Dowdy AJ; Nokes GW; Luetscher JA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
    Textor SC; Bravo EL; Fouad FM; Tarazi RC
    Am J Med; 1982 Nov; 73(5):719-25. PubMed ID: 6291388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension].
    Plouin PF; Ménard J; Corvol P
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3234-8. PubMed ID: 1219630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.